|
Dr. Stegmann is the cardiac surgeon who pioneered the procedure upon which CVBT was founded. For the past 12 years, he has been working in the area of neo-angiogenesis and human growth factors, prompting a discovery that opens a new area of biotechnology and medical treatment for the treatment of cardiovascular disease. Besides various scientific publications, he has since authored New Vessels for the Heart, [LINK TO A3] the story of his discovery and its development.
Since December 1984, Dr. Stegmann has held the position of Professor of Surgery and Director of the Department for Thoracic and Cardiovascular Surgery at the Fulda Medical Center in Germany, a major medical and teaching hospital serving the University of Marburg and the greater Frankfurt, Germany area. He is also a member of the faculty of Hannover Medical School in Germany. He received his medical degree (summa cum laude) from Heidelberg University, Heidelberg, Germany. | 